Related Experiment Video
Updated: May 12, 2025

In Vitro Apical-Out Enteroid Model of Necrotizing Enterocolitis
Published on: June 8, 2022
Defining enteric bacterial pathogenesis using organoids: Citrobacter rodentium uses EspC, an atypical mucinolytic
Yan Chen1, Ashley Gilliland1, Qiaochu Liang1
1Division of Gastroenterology, Department of Pediatrics, University of British Columbia, Vancouver, BC, Canada.
Abstract:
Enteric bacterial pathogens pose significant threats to human health; however, the mechanisms by which they infect the mammalian gut in the face of daunting host defenses remain to be fully defined. For the attaching and effacing (A/E) bacterial family member and murine pathogen Citrobacter rodentium, its virulence strategy appears to involve penetration of the colonic mucus barrier to reach the underlying epithelium. To better define these interactions, we grew colonoids under air-liquid interface (ALI) conditions, producing a thick mucus layer that mimicked in vivo mucus composition and glycosylation. C. rodentium's penetration of ALI-derived mucus was dramatically enhanced upon exposure to sialic acid, in concert with the secretion of two serine protease autotransporter of Enterobacteriaceae (SPATE) proteins, Pic and EspC. Despite Pic being a class II SPATE, and already recognized as a mucinase, it was EspC, a class I SPATE family member, that degraded ALI-derived mucus, despite class I SPATEs not previously shown to possess mucinase activity. Confirming this finding, E. coli DH5α carrying a plasmid that expresses C. rodentium-derived EspC was able to degrade the mucus. Moreover, recombinant EspC alone also displayed mucinolytic activity in a dose-dependent manner. Collectively, our results reveal the utility of ALI-derived mucus in modeling microbe-host interactions at the intestinal mucosal surface, as well as identify EspC as an atypical class I SPATE that shows significant mucinolytic activity toward ALI-derived mucus.
Insights
Citrobacter rodentium uses EspC, a serine protease autotransporter of Enterobacteriaceae (SPATE), to degrade the colonic mucus barrier. This study identifies EspC as an atypical mucinase, aiding bacterial gut infection.
Area of Science:
- Microbiology
- Gastroenterology
- Pathogen-host interactions
Background:
- Enteric bacterial pathogens threaten human health by infecting the gut.
- Mechanisms of gut infection are not fully understood, especially against host defenses.
- Citrobacter rodentium, an attaching and effacing pathogen, likely penetrates the mucus barrier.
Purpose of the Study:
- To investigate the role of mucus barrier penetration in C. rodentium infection.
- To define the interactions between C. rodentium and the colonic mucus layer.
- To identify bacterial factors involved in mucus degradation.
Main Methods:
- Cultured colonoids under air-liquid interface (ALI) to mimic in vivo mucus.
- Assessed C. rodentium mucus penetration with and without sialic acid exposure.
- Analyzed the role of SPATE proteins Pic and EspC in mucus degradation.
- Utilized E. coli expressing C. rodentium EspC and recombinant EspC for validation.
Main Results:
- ALI-derived mucus mimicked in vivo mucus composition and glycosylation.
- Sialic acid enhanced C. rodentium mucus penetration, linked to Pic and EspC secretion.
- EspC, an atypical class I SPATE, degraded ALI-derived mucus, unlike previously known class I SPATEs.
- Recombinant EspC demonstrated dose-dependent mucinolytic activity.
Conclusions:
- ALI-derived mucus is a useful model for studying gut mucosal interactions.
- EspC is identified as a novel mucinase with significant activity against ALI-derived mucus.
- This finding reclassifies EspC's function within the SPATE family and sheds light on C. rodentium virulence.
More Related Videos
07:59Adapting Gastrointestinal Organoids for Pathogen Infection and Single Cell Sequencing under Biosafety Level 3 BSL-3 Conditions
Published on: September 10, 2021
10:59Using Human Induced Pluripotent Stem Cell-derived Intestinal Organoids to Study and Modify Epithelial Cell Protection Against Salmonella and Other Pathogens
Published on: May 12, 2019